Aceto Corp (ACET): Douglas A Roth , Sr. Vice President & CFO of Aceto Corp sold 7,000 shares on May 26, 2016. The Insider selling transaction was reported by the company on May 27, 2016 to the Securities and Exchange Commission. The shares were sold at $22.16 per share for a total value of $155,120.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Mar 14, 2016, Raymond Bartone (Senior Vice President) sold 3,000 shares at $22.40 per share price.On Mar 8, 2016, Hans C Noetzli (director) sold 6,500 shares at $22.91 per share price.Also, On Mar 4, 2016, Frank Debenedittis (Sr. Vice President) sold 3,000 shares at $21.98 per share price.On Feb 25, 2016, Albert L Eilender (Chairman) sold 9,281 shares at $21.79 per share price.
Aceto Corporation: On Wednesday, May 25, 2016 heightened volatility was witnessed in Aceto Corporation which led to swings in the share price. The shares opened for trading at $21.93 and hit $22.56 on the upside , eventually ending the session at $22.38, with a gain of 1.96% or 0.43 points. The heightened volatility saw the trading volume jump to 1,68,257 shares. The 52-week high of the share price is $32.2 and the company has a market cap of $662 M . The 52-week low of the share price is at $19.204.
On May 5, 2016, Aceto Corporation announced a cash dividend of $0.0600. The company’s management has announced Jun 7, 2016 as the ex-dividend date and fixed the record date on Jun 9, 2016. The payable date has been fixed on Jun 24, 2016.
Company has been under the radar of several Street Analysts.Aceto Corporation is Initiated by First Analysis Sec to Overweight and the brokerage firm has set the Price Target at $30. The Rating was issued on Mar 31, 2016.
Aceto Corporation (Aceto) is engaged in marketing sales and distribution of finished dosage form generic pharmaceuticals nutraceutical products pharmaceutical active ingredients and intermediates specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three segments: Human Health Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment has two product groups: Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products. The Company has operations in China Germany France the Netherlands Singapore India Hong Kong Philippines the United Kingdom and the United States.